Skip to main content
Clinical Trials/NCT03379480
NCT03379480
Completed
Not Applicable

Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia

National Institute of Mental Health and Neuro Sciences, India1 site in 1 country96 target enrollmentNovember 11, 2016
ConditionsSchizophrenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Enrollment
96
Locations
1
Primary Endpoint
Improvement in negative symptoms in patients with schizophrenia
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to examine whether yoga is efficacious as an add-on treatment for negative symptoms of schizophrenia in a randomized multi-centric trial and also to examine functional brain changes associated with self-reflection after treatment with yoga.

Registry
clinicaltrials.gov
Start Date
November 11, 2016
End Date
June 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Institute of Mental Health and Neuro Sciences, India
Responsible Party
Principal Investigator
Principal Investigator

Dr Naren P Rao

Associate Professor ,Department of Psychiatry, NIMHANS

National Institute of Mental Health and Neuro Sciences, India

Eligibility Criteria

Inclusion Criteria

  • Schizophrenia Subject
  • ICD (International Classification of Diseases) 10 diagnosis of schizophrenia
  • capacity to provide informed consent, as evaluated by the MacArthur Competence Assessment Tool for Clinical Research
  • no other current comorbid axis I diagnosis (except nicotine abuse/dependence) and no general impaired intellectual functioning
  • Healthy volunteers:
  • Males and females between 18 and 45 years
  • Capacity to provide informed consent
  • absence of past or present psychiatric illnesses including substance abuse 4) no general impaired intellectual functioning (MMSE above24)

Exclusion Criteria

  • Other current comorbid axis I diagnosis (except nicotine abuse/dependence) and general impaired intellectual functioning
  • History of alcohol or substance abuse or dependence in the last 12 months (with the exception of nicotine)
  • Any Contraindication to MRI like metal implants or paramagnetic objects within the body or claustrophobia (only for patients undergoing fMRI at NIMHANS)
  • Past history of head injury resulting in loss of consciousness or neurosurgery
  • Concomitant severe medical conditions
  • Change in dose of antipsychotic medication or Electroconvulsive therapy in the past 6weeks
  • Pregnant or lactating -

Outcomes

Primary Outcomes

Improvement in negative symptoms in patients with schizophrenia

Time Frame: At the end of 12 weeks of yoga

Schizophrenia patients receiving yoga as add-on treatment will have significant improvement in negative symptoms after yoga therapy compared to those in the wait-list group as reflected by a greater decrease in Scale for Assessment of negative symptoms score. This scale measures negative symptoms on a 25 item, 6-point scale. Items are listed under the five domains of affective blunting, alogia, avolition/apathy, anhedonia/asociality, and attention. A higher score indicates greater severity.

Secondary Outcomes

  • fMRI changes(At the end of 12weeks)

Study Sites (1)

Loading locations...

Similar Trials